US Department Of Defense Awards Grant to Ichor Medical Systems, Inc. to Evaluate Skin Electroporation Device tor Delivery of Multi-Agent Dna Vaccines
4/18/2011 10:23:01 AM
More...
|
Vaxonco, Inc.'s EP1300 Epitope-Based DNA Vaccine for Malaria Delivered by Ichor Medical Systems, Inc. TriGrid(TM) Electoporation Enters Phase I Trial
9/23/2010 11:55:13 AM
More...
|
Ichor Medical Systems, Inc. and Profectus BioSciences, Inc. Enter into an Agreement for Use of TriGrid(TM) Electroporation Device to Develop Multiple DNA Vaccines
3/2/2010 10:28:38 AM
More...
|
Ichor Medical Systems, Inc. Awarded $3.3 Million National Institutes of Health (NIH) Grant to Develop Alzheimer's Disease Vaccine
8/5/2009 9:35:22 AM
More...
|
Ichor Medical Systems, Inc. Melanoma Vaccine Clinical Trial Moves to Highest Dose Level
3/4/2008 11:55:46 AM
More...
|
Ichor Medical Systems, Inc.'s TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine
10/1/2007 9:42:15 AM
More...
|
Navy Partners with Ichor Medical Systems, Inc. to Develop a Vaccine for Anthrax and Plague
8/6/2007 12:14:13 PM
More...
|
FDA Approves Phase I Clinical Trial Using Ichor Medical Systems, Inc.'s TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering
5/14/2007 11:22:54 AM
More...
|
Interferon Beta DNA Treatment Delivered with Ichor Medical Systems, Inc. Technology Reduces Atherosclerosis Progression in Mice
3/27/2007 3:31:20 AM
More...
|
United States Department of Defense Selects Ichor Medical Systems, Inc. to Develop Biodefense Vaccine
3/12/2007 12:57:57 PM
More...
|
|